Blog
4 Hollywood Franchises That Suffered Major Setbacks in 2017
It's been a bit of a rough year at the movies, and while franchise entries like Wonder Woman, Guardians of the Galaxy Vol. 2, and Despicable Me 3 proved to be big hits, 2017 has seen a surprising....
Raven Industries Wins New Business in a Strong Quarter
Raven Industries (NASDAQ: RAVN) released fiscal second-quarter 2018 results on Aug. 23 after the market closed, highlighting continued broad-based growth, a recent acquisition, and welcome....
Williams-Sonoma, Inc. Accelerates Comps in a Strong Quarter
Williams-Sonoma (NYSE: WSM) announced second-quarter 2017 results on Aug. 23 after the market closed, with the home-furnishings retailer highlighting solid comparable-brand revenue growth and....
The Hidden Gold Mine in ExxonMobil's Q2 2017 Earnings
You'd never think that anything about oil industry giant ExxonMobil (NYSE: XOM) would be overlooked. As an oil major, and a Dow Jones Industrial Average and S&P 500 component, the company has....
3 Top Stocks Wall Street Insiders Love
What do "Wall Street insiders" love? For starters, they like a lot of the same things other investors like: great growth stories, value-priced shares, and promising turnarounds. But there are some....
Why I Love BofI Holding Inc.
BofI Holding (NASDAQ: BOFI) isn't exactly a household name -- yet. With around $9 billion in assets, the bank is less than half of 1% the size of the largest U.S. banks, so it's not surprising....
3 Stocks That Could Put Nvidia's Returns to Shame
Shares of graphics-chip company NVIDIA tripled in 2016, and they've gained another 60% this year. Not only is the core gaming business booming, but NVIDIA's bets on deep learning, self-driving....
NVIDIA Beefs Up Its Driverless Truck Muscle
NVIDIA (NASDAQ: NVDA) said last week that it participated in a more than $20 million funding round into TuSimple, a Chinese start-up that's developing self-driving technology for long-haul....
3 Key Metrics Mondelez International Inc Investors Need to Focus On
Consumers around the world are making healthier choices about the snacks they eat. According to Nielsen, 70% of those survey respondents make dietary choices to prevent health problems like high....
Will Wal-Mart Make a Shopping Giant Out of Google Express?
Wal-Mart Stores (NYSE: WMT) just teamed up with Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL). The Google Express service already featured 46 retail partners, but none with the market heft of Sam....
Top 3 Stocks for Retirees to Consider
Retirement means you no longer need to work to make a living. But that doesn't mean your money needs to stop working for you. For those who know where to look, the stock market can be fantastic....
Are You Too Old to Buy a House?
Is there an age at which the dream of home ownership has passed? Absolutely not! However, when you're buying a home later in life, you have different considerations to make or your dream home....
9 Must-See Metrics That Highlight salesforce.com, inc.'s Second Quarter
Enterprise cloud company salesforce.com (NYSE: CRM) just posted its results for its second quarter of fiscal 2018, and they didn't disappoint. Thanks to continued rapid top-line growth during the....
3 High-Yield Dividend Stocks for Conservative Investors
High-yield dividend stocks tend to be particularly risky types of investing vehicles that aren't well-suited for conservative individuals. Even so, there are a handful of rare gems that do, in....
5 Things to Know About Cash-Back Credit Cards
The best cash-back card offers promise unlimited rewards that equate to money back on every purchase you make. Over time, these rebates can add up to hundreds or thousands of dollars in value,....
3 Stocks to Hold for the Next 50 Years
The easiest, and often best, way to invest is to buy a company and hold it long term. And if you're holding a stock for the next 50 years, that's very, very long term. We asked three Motley Fool....
Why Stryker, Ultragenyx Pharmaceutical, and La-Z-Boy Slumped Today
Major benchmarks trended downward Wednesday, taking a break from the rally that had boosted stocks in the previous session. Investors seemed uncertain about President Donald Trump's plans to....
What Happened in the Stock Market Today
Stocks fell on Wednesday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) both slightly losing ground.Data source: Yahoo! Finance.Real estate was a....
Why Fiat Chrysler Automobiles, Intra-Cellular Therapies, and Express Jumped Today
Stocks closed down Wednesday following a broad rally the day before, and the market turned its attention to President Donald Trump's threat to discontinue U.S. participation in the North American....
3 Value Stocks for Bold Investors
While the market continues to bump up against new all-time highs, not every stock has joined in on the rally. Three that caught our eye as potential values in today's heated market are NVR (NYSE:....
Why Petmed Express Inc's Shares Plunged 19% Today
Shares of Petmed Express Inc (NASDAQ: PETS) dropped as much as 19% in trading Wednesday after short-seller Aurelius Value laid out how it thinks the company is using opiates to fuel growth. At....
Here's What's Pushing Up 22nd Century Group Inc. Stock Today
Shares of 22nd Century Group Inc. (NYSEMKT: XXII), a plant biotechnology company focused on tobacco-harm reduction, popped 12.3% higher before settling to a gain of about 6.9% as of 3:22 p.m. EDT....
Why Seaspan Corporation Stock Just Jumped 10%
Shares of containership operator Seaspan (NYSE: SSW) are up 10% as of 2:45 p.m. EDT after the company provided investors with a "vessel update" in the form of a press release. As the company....
Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much
Two members of the U.S. House of Representatives Committee on Oversight and Government Reform want to know why the prices of multiple sclerosis (MS) drugs are so high. Rep. Elijah Cummings (D-Md.)....
Why Ultragenyx Pharmaceutical Stock Is Sinking Today
Shares of the rare-disease drugmaker Ultragenyx Pharmaceutical (NASDAQ: RARE) are under pressure today after the company announced that its late-stage study assessing aceneuramic acid extended....